Welcome to Peptide Card of AntiTbPdb
| This page displays user query in tabular form. |
GWGSFFKKAAHVGKHVGKAALTHYL details |
| Primary information | |
|---|---|
| ID | antitb_1360, |
| Name | 10898673 |
| N-Terminal modification | Pleurocidin |
| C-Terminal Modification | GWGSFFKKAAHVGKHVGKAALTHYL |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 25 |
| Source | L |
| Species | Natural |
| Strain | Pleuronectes americanus |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis |
| Cell Line | MIC = 80 μg/ml |
| Inhibition Concentration | In vitro |
| Sequence | 2000 |
| Cytotoxicity | None |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | Antibacterial against P.aeruginosa, K.pneumoniae,S.aureus and C.albicans |
| Tertiary Structure (Technique) | Not Predicted), |
| Primary information | |
|---|---|
| ID | antitb_1361, |
| Name | 10898673 |
| N-Terminal modification | Pleurocidin |
| C-Terminal Modification | GWGSFFKKAAHVGKHVGKAALTHYL |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 25 |
| Source | L |
| Species | Natural |
| Strain | Pleuronectes americanus |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis |
| Cell Line | MIC = 20 μg/ml |
| Inhibition Concentration | In vitro |
| Sequence | 2000 |
| Cytotoxicity | None |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | 185 μM OF D-CYCLOSERINE DRUG + 5.2 μM OF Peptide reduces ~ 4 time MIC of drug |
| Year of Publication | Antibacterial against P.aeruginosa, K.pneumoniae,S.aureus and C.albicans |
| Tertiary Structure (Technique) | Not Predicted), |